ArticleInternational journal of ophthalmology2026
Clinical and multimodal imaging characteristics of acute central serous chorioretinopathy with fibrinous exudation.
Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo analyze the clinical and multimodal imaging characteristics of acute central serous chorioretinopathy (CSC) with or without fibrinous exudation.
methodsRetrospective case-control study. Patients diagnosed with acute CSC with fibrinous exudation (FE group) and without fibrinous exudation (non-FE group) were consecutively included. The clinical data and multimodal images including color fundus photography, fundus autofluorescence, spectral-domain optical coherence tomography (OCT), fundus fluorescein angiography, and indocyanine green angiography at presentation were recorded. Treatment method, follow-up outcomes including best-corrected visual acuity (BCVA) and OCT characteristics were also documented.
resultsThe FE group (
conclusionFibrinous exudation in acute CSC is a multimodal imaging biomarker indicative of severe choroidal vasculopathy and retinal pigment epithelium barrier failure. Recognizing this entity and understanding its potential mechanisms are crucial for managing patient prognosis and may guide future targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.